Encompass Health Corporation
EHC
$107.49
-$0.59-0.55%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 28.38% | 20.84% | 16.91% | 24.54% | 34.67% |
| Total Depreciation and Amortization | 10.23% | 10.77% | 5.10% | 9.60% | 12.66% |
| Total Amortization of Deferred Charges | -- | -1.03% | -- | -- | -- |
| Total Other Non-Cash Items | -0.46% | 33.53% | 23.41% | 23.46% | 13.54% |
| Change in Net Operating Assets | -350.67% | 396.43% | -94.46% | 66.95% | -368.75% |
| Cash from Operations | 8.49% | 24.10% | 1.12% | 24.29% | 20.85% |
| Capital Expenditure | 0.43% | -15.40% | -26.85% | 0.00% | -17.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 167.39% | -102.00% | -1.43% | -466.67% | -52.58% |
| Cash from Investing | 5.30% | -17.53% | -24.64% | -4.42% | -22.21% |
| Total Debt Issued | 600.00% | 133.33% | 433.33% | -- | 20.00% |
| Total Debt Repaid | -312.50% | 76.06% | 30.61% | -70.23% | -60.00% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -97.50% | -918.67% | -266.18% | -47.62% | -328.93% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -12.78% | -11.76% | -13.33% | -14.77% | -13.21% |
| Other Financing Activities | -72.10% | -12.56% | -157.86% | -441.67% | -221.43% |
| Cash from Financing | 21.40% | 35.45% | -26.48% | -81.85% | -221.18% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 20,266.67% | 112.14% | -360.12% | 55.32% | -100.44% |